Distributed by: DocRx — Class III drug recall D-0330-2021
Ongoing recall by Asclemed USA Inc. dba Enovachem Pharmaceuticals, reported 2021-04-21, distributed in CA, LA. Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instru
| Recall number | D-0330-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Asclemed USA Inc. dba Enovachem Pharmaceuticals, Torrance, CA, United States |
| Recall initiated | 2021-03-19 |
| Classified | 2021-04-12 |
| Reported by FDA | 2021-04-21 |
| Distributed | CA, LA |
| Reason classes | labeling |
| NDC | 59746-0001-03, 69306-0004-21 |
| Lot numbers | 20K0043P, 20L0026P |
| Expiration dates | 2022-08-31, 2022-09-30 |
Product
Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608
Reason for recall
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0330-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.